|1|Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma. (24418330)
Cui W.... Zhou X.
|2|Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy. (23807169)
Cheah C.Y.... Seymour J.F.
|3|Predictive value of interim A^a8,F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment. (23880897)
GonzA!lez-Barca E.... Caballero D.
|4|Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? - Response to Landsburg etA al. (24329994)
Westin J.... Fayad L.
|5|A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma. (24032456)
Coiffier B.... Lisby S.
|6|At diagnosis, diffuse large B-cell lymphoma patients show impaired rituximab-mediated NK-cell cytotoxicity. (23400905)
Danielou-Lazareth A.... Dulphy N.
|7|Epigenetic approaches for chemosensitization of refractory diffuse large B-cell lymphomas. (24019329)
Steinhardt J.J.... Gartenhaus R.B.
|8|Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study. (22957852)
Keegan T.H.... Glaser S.L.
|9|Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens. (24141331)
Li Y.L.... Zhai Z.M.
|10|Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma. (23721513)
Zang C.... Scholz C.W.
|11|Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry. (24318593)
van der Poel M.W.... van de Poll-Franse L.V.
|12|The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies. (23869078)
Carbone A.... Gloghini A.
|13|Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement. (24220305)
Kim S.... Lee D.
|14|Features and outcomes of diffuse large B-cell lymphoma of the thyroid in a large contemporary cohort. (23647064)
Costa L.J.... Xavier A.C.
|15|Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer/testis antigens in diffuse large B-cell testicular lymphoma. (23680437)
Hudolin T.... Mengus C.
|16|The sequence of events in diffuse large B-cell lymphoma. (23950172)
|17|Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone. (23320009)
Ohe M.... Hattori A.
|18|Gene expression-based risk score in diffuse large B-cell lymphoma. (23482333)
Bret C.... Moreaux J.
|19|Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma. (23233611)
|20|Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (22997459)
Tilly H.... Dreyling M.
|21|Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas. (21638516)
Guney S.... Bastard C.
|22|Diffuse large B-cell lymphoma with germinal center B-cell phenotype mimicking primary effusion lymphoma. (21220599)
Lim Y.... Kim K.H.
|23|Correlation between the expressions of CARMA1 gene and MUM1 and its significance in diffuse large B cell lymphoma]. (21569705)
Chen Y.M.... Zhong Y.
|24|Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lymphoma. (21702643)
Karmali R.... Venugopal P.
|25|Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. (22125456)
Lu Y.... Wang S.S.
|26|A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma. (20395518)
Schniederjan S.D.... Mann K.P.
|27|Vav-1 expression correlates with NFI_B activation and CD40-mediated cell death in diffuse large B-cell lymphoma cell lines. (20155735)
Hollmann A.... Tzankov A.
|28|Multiple bone lesions and hypercalcemia presented in diffuse large B cell lymphoma: mimicking multiple myeloma? (20379806)
Chen P.... Fu J.
|29|Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. (19903857)
Cattoretti G.... Maclennan A.J.
|30|ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma. (18368067)
Ushmorov A.... Wirth T.
|31|Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome. (19019774)
Czuchlewski D.R.... Cesarman E.
|32|Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kappaB pathway as a target for new therapeutic strategies. (19021048)
Pavan A.... De Re V.
|33|Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas. (17360630)
Polo J.M.... Melnick A.
|34|Persistent anemia in a patient with diffuse large B cell lymphoma: pure red cell aplasia associated with latent Epstein-Barr virus infection in bone marrow. (17923747)
Sung H.J.... Kim J.S.
|35|Expression of c-FLIP is primarily detected in diffuse large B-cell lymphoma and Hodgkin's lymphoma and correlates with lack of caspase 8 activation. (18042067)
van Houdt I.S.... Oudejans J.J.
|36|Common variable immunodeficiency patient with large granular lymphocytosis developing extranodal diffuse large B-cell lymphoma: a case report. (17194667)
Delia M.... Liso A.
|37|Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome. (16494623)
Kojima Y.... Moriwaki H.
|38|A 65-year-old woman with a left occipital lobe tumor. Diffuse large B-Cell, primary central nervous system lymphoma. (16740056)
Nagel S.J.... Weil R.J.
|39|Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. (15709173)
Banham A.H.... Gascoyne R.D.
|40|A case of pure red cell aplasia complicated with diffuse large B cell lymphoma, T-cell-rich/histiocyte-rich variant: effectiveness of rituximab and implications for a common immunopathogenic role of B lymphocytes. (15870490)
Oyaizu N.... Mori S.
|41|Diffuse large B-cell primary gastric lymphoma treated successfully with the CD20 monoclonal antibody (rituximab): a case with severe liver dysfunction due to liver cirrhosis and hepatocellular carcinoma. (15870922)
Nakai S.... Kuriyama S.
|42|Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas. (15576477)
Muris J.J.... Oudejans J.J.
|43|The interplay between c-Myc oncogene expression and circulating vascular endothelial growth factor (sVEGF), its antagonist receptor, soluble Flt-1 in diffuse large B cell lymphoma (DLBCL): relationship to patient outcome. (15160911)
Aref S.... El Askalany H.
|44|Cluster analysis of apoptosis-associated bcl2 family proteins in diffuse large B-cell lymphomas. Relations with the apoptotic index, the proliferation profile and the B-cell differentiation immunophenotypes. (15517919)
Bai M.... Kanavaros P.
|45|The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. (12933571)
Savage K.J.... Shipp M.A.
|46|Analysis of immunoglobulin VH genes in CD10-positive diffuse large B-cell lymphoma. (12406188)
Hojo H.... Abe M.
|47|Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive and -negative diffuse large B cell lymphoma. (11237070)
Nakamura N.... Abe M.
|48|CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma. (10102615)
Fang J.M.... Variakojis D.
|49|Diffuse large B-cell lymphoma mainly involving the heart and showing t(8;14) (q24;q32) with c-myc rearrangement]. (9364867)
Takai K.... Shibuya H.
|50|Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. (8683246)
Kramer M.H.... Kluin P.M.